Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
China · Delayed Price · Currency is CNY 41.67
-1.31 (-3.05%)
Aug 21, 2026, 3:04 PM CST
SHE:300049 Market Cap
SHE:300049 has a market cap or net worth of 11 billion as of August 21, 2026. Its market cap has decreased by -41.77% in one year.
Market Cap
11.00B
Enterprise Value
10.83B
Revenue
1.63B
Ranking
n/a
PE Ratio
70.71
Stock Price
41.67
ChartMarket Cap Chart
Since January 20, 2010, SHE:300049's market cap has increased from 2.54B to 11.00B, an increase of 333.52%. That is a compound annual growth rate of 9.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 11.00B | -41.04% |
| Dec 31, 2025 | 18.66B | 122.08% |
| Dec 31, 2024 | 8.40B | -26.74% |
| Dec 29, 2023 | 11.47B | 78.43% |
| Dec 30, 2022 | 6.43B | 70.55% |
| Dec 31, 2021 | 3.77B | 80.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mabwell (Shanghai) Bioscience | 13.35B |
| Nanjing Vazyme Biotech | 13.19B |
| InventisBio | 12.41B |
| Tibet Cheezheng Tibetan Medicine | 11.38B |
| Chengdu Olymvax Biopharmaceuticals | 11.08B |
| Staidson (Beijing) BioPharmaceuticals | 10.95B |
| Chengzhi | 10.87B |
| Pacific Shuanglin Bio-pharmacy | 10.49B |